Literature DB >> 30467419

Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Miguel Álvaro-Benito1, Eliot Morrison2, Friederike Ebner3, Esam T Abualrous4, Marie Urbicht2, Marek Wieczorek2, Christian Freund5.   

Abstract

Classical human leukocyte antigen (HLA) molecules of the major histocompatibility class II (MHCII) complex present peptides for the development, surveillance and activation of CD4+ T cells. The nonclassical MHCII-like protein HLA-DM (DM) catalyzes the exchange and loading of peptides onto MHCII molecules, thereby shaping MHCII immunopeptidomes. Natural variations of DM in both chains of the protein (DMA and DMB) have been hypothesized to impact peptide presentation, but no evidence for altered function has been reported. Here we define the presence of DM allotypes in human populations covered by the 1000 Genomes Project and probe their activity. The functional properties of several allotypes are investigated and show strong enhancement of peptide-induced T cell activation for a particular combination of DMA and DMB. Biochemical evidence suggests a broader pH activity profile for the new variant relative to that of the most commonly expressed DM allotype. Immunopeptidome analysis indicates that the compartmental activity of the new DM heterodimer extends beyond the late endosome and suggests that the natural variation of DM has profound effects on adaptive immunity when antigens bypass the canonical processing pathway.

Entities:  

Keywords:  Epitope selection; HLA-DM, Peptide editing; Immunopeptidome; Limited polymorphism; MHC class II

Mesh:

Substances:

Year:  2018        PMID: 30467419      PMCID: PMC7000412          DOI: 10.1038/s41423-018-0181-1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  50 in total

1.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

2.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes.

Authors:  E Mellins; L Smith; B Arp; T Cotner; E Celis; D Pious
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

3.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

4.  Distinct antigen MHC class II complexes generated by separate processing pathways.

Authors:  R Lindner; E R Unanue
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

Review 5.  Variations in MHC Class II Antigen Processing and Presentation in Health and Disease.

Authors:  Emil R Unanue; Vito Turk; Jacques Neefjes
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

Review 6.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

7.  An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.

Authors:  Tieying Hou; Henriette Macmillan; Zhenjun Chen; Catherine L Keech; Xi Jin; John Sidney; Michael Strohman; Taejin Yoon; Elizabeth D Mellins
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

8.  HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.

Authors:  Shereen Amria; Laela M Hajiaghamohseni; Caroline Harbeson; Dan Zhao; Oliver Goldstein; Janice S Blum; Azizul Haque
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  MHC class II complexes sample intermediate states along the peptide exchange pathway.

Authors:  Marek Wieczorek; Jana Sticht; Sebastian Stolzenberg; Sebastian Günther; Christoph Wehmeyer; Zeina El Habre; Miguel Álvaro-Benito; Frank Noé; Christian Freund
Journal:  Nat Commun       Date:  2016-11-09       Impact factor: 14.919

View more
  6 in total

1.  Natural variation of ncHLAII molecules: challenges and perspectives.

Authors:  Miguel Álvaro-Benito
Journal:  Cell Mol Immunol       Date:  2022-08-26       Impact factor: 22.096

2.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

Review 3.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

4.  A Missing Switch in Peptide Exchange for MHC Class II Molecules.

Authors:  Christian Freund; Thomas Höfer
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

5.  Type 1 Diabetes and the HLA Region: Genetic Association Besides Classical HLA Class II Genes.

Authors:  Jana Sticht; Miguel Álvaro-Benito; Stefan Konigorski
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

6.  CD4+ Th immunogenicity of the Ascaris spp. secreted products.

Authors:  Friederike Ebner; Miguel Álvaro-Benito; Eliot Morrison; Miriam Bertazzon; Ankur Midha; Susanne Hartmann; Christian Freund
Journal:  NPJ Vaccines       Date:  2020-03-20       Impact factor: 7.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.